Moderna MRNA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$1.34B-62.6% | -$826M-313% | -$200M+75.8% | -$825M+15.0% | -$971M+13.3% | ||
| $59M-11.9% | $67M+28.8% | $52M-8.8% | $57M+46.2% | $39M-35.0% | ||
| $104M-8.0% | $113M-9.6% | $125M-3.8% | $130M+13.0% | $115M+10.6% | ||
| -$630M— | —— | -$847M+7.8% | -$919M+11.4% | -$1.04B— | ||
| $62M+59.0% | $39M+18.2% | $33M+1,000% | $3M-97.4% | $117M-77.6% | ||
| -$76M— | $0-100% | $700M+24.1% | $564M-22.7% | $730M— | ||
| —— | $150M0.0% | $150M0.0% | $150M0.0% | $150M— | ||
| $17M-97.1% | $581M— | $0-100% | $9M+125% | $4M— | ||
| -$688M-147% | $1.46B+1,095% | -$147M+57.4% | -$345M-13.9% | -$303M— | ||
| -$692M— | —— | -$880M+4.6% | -$922M+20.1% | -$1.15B— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
